Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04782687
Title Phase II Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors US Oncology Research
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.